Alternatives to Polysomnography for the Diagnosis of Pediatric Obstructive Sleep Apnea

Taylor B Teplitzky1, Audrey J Zauher1, Amal Isaiah1,2,3

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Insights

Diagnosing childhood obstructive sleep apnea (OSA) typically requires polysomnography (PSG), which presents challenges. Current alternatives like wearable devices and home-based PSG are not yet validated replacements for diagnosing pediatric sleep-disordered breathing (SDB).

Area of Science:

  • Pediatric Pulmonology
  • Sleep Medicine
  • Biomedical Engineering

Background:

  • Obstructive sleep apnea (OSA) diagnosis in children necessitates hospital-based polysomnography (PSG).
  • PSG presents significant challenges for pediatric patients and families, including cost, accessibility, and discomfort.
  • There is a critical need for less burdensome methods to assess pediatric sleep-disordered breathing (SDB).

Purpose of the Study:

  • To review and evaluate alternative methods for assessing pediatric SDB.
  • To determine the current validity of alternative diagnostic tools compared to PSG.
  • To explore the potential role of emerging technologies in pediatric sleep apnea evaluation.

Main Methods:

  • Literature review of studies evaluating alternative diagnostic methods for pediatric SDB.
  • Analysis of data from wearable devices, single-channel recordings, and home-based PSG.
  • Assessment of the current validation status of these alternative methods against level I PSG.

Main Results:

  • Wearable devices, single-channel recordings, and home-based PSG are not yet validated as replacements for pediatric PSG.
  • These alternative methods may serve as preliminary screening tools or aid in risk stratification for pediatric OSA.
  • Further research is required to establish the predictive value of combined metrics from these alternative approaches.

Conclusions:

  • Current alternative methods for diagnosing pediatric SDB lack sufficient validation to replace PSG.
  • Emerging technologies show promise for screening and risk stratification but require further investigation.
  • Future studies should focus on validating combined metrics to accurately predict pediatric OSA.